Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient. Xara J, Relvas M, Figueiredo C, Calvao J, et al. Int J Dermatol 2023;62:e617-e618.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xara J, Relvas M, Figueiredo C, Calvao J, et al. Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient. Int J Dermatol 2023;62:e617-e618.
PMID: 37622659